logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On April 29, WEIGAO GROUP (01066) spent HK$46.69 thousand to repurchase 13.2 thousand shares.

date
17:29 29/04/2026
avatar
GMT Eight
V Power Group (01066) announced that on April 29, 2026, they repurchased 132,000 shares for 466,900 Hong Kong dollars.
WEIGAO GROUP (01066) announced on 29th April 2026 that it will spend HK$46.69 million to repurchase 132,000 shares.
Related Articles
HK Stock
ARTA TECHFIN (00279) completes the placement of a total of 123 million shares, raising approximately 59.8 million Hong Kong dollars.
HK Stock
JF SMARTINVEST (09636) repurchased approximately 70,500 shares for about HKD 2.3196 million on April 29th.
HK Stock
CSPC PHARMA (01093): Liposomal Amphotericin B for Injection (HC1507G2) Approved for Marketing Authorization Application in Europe.
ARTA TECHFIN (00279) completes the placement of a total of 123 million shares, raising approximately 59.8 million Hong Kong dollars.
HK Stock
JF SMARTINVEST (09636) repurchased approximately 70,500 shares for about HKD 2.3196 million on April 29th.
HK Stock
CSPC PHARMA (01093): Liposomal Amphotericin B for Injection (HC1507G2) Approved for Marketing Authorization Application in Europe.
HK Stock
RECOMMEND
China Leads as Humanoid Robotics Reach Commercial Turning Point
China Leads as Humanoid Robotics Reach Commercial Turning Point
icon
29/04/2026
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
icon
29/04/2026
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
icon
29/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.